Cancer Stem Cell and Aggressiveness Traits Are Promoted by Stable Endothelin-Converting Enzyme-1c in Glioblastoma Cells
dc.contributor.author | Niechi, Ignacio | |
dc.contributor.author | Erices, Jose I. | |
dc.contributor.author | Carrillo-Beltran, Diego | |
dc.contributor.author | Uribe-Ojeda, Atenea | |
dc.contributor.author | Torres, Angelo | |
dc.contributor.author | Rocha, Jose Dellis | |
dc.contributor.author | Uribe, Daniel | |
dc.contributor.author | Toro, Maria A. | |
dc.contributor.author | Villalobos-Nova, Karla | |
dc.contributor.author | Gaete-Ramirez, Belen | |
dc.contributor.author | Mingo, Gabriel | |
dc.contributor.author | Owen, Gareth I. I. | |
dc.contributor.author | Varas-Godoy, Manuel | |
dc.contributor.author | Jara, Lilian | |
dc.contributor.author | Aguayo, Francisco | |
dc.contributor.author | Burzio, Veronica A. | |
dc.contributor.author | Quezada-Monras, Claudia | |
dc.contributor.author | Tapia, Julio C. C. | |
dc.date.accessioned | 2025-01-20T20:18:02Z | |
dc.date.available | 2025-01-20T20:18:02Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Glioblastoma (GBM) is the most common and aggressive type of brain tumor due to its elevated recurrence following treatments. This is mainly mediated by a subpopulation of cells with stemness traits termed glioblastoma stem-like cells (GSCs), which are extremely resistant to anti-neoplastic drugs. Thus, an advancement in the understanding of the molecular processes underlying GSC occurrence should contribute significantly towards progress in reducing aggressiveness. High levels of endothelin-converting enzyme-1 (ECE1), key for endothelin-1 (ET-1) peptide activation, have been linked to the malignant progression of GBM. There are four known isoforms of ECE1 that activate ET-1, which only differ in their cytoplasmic N-terminal sequences. Isoform ECE1c is phosphorylated at Ser-18 and Ser-20 by protein kinase CK2, which increases its stability and hence promotes aggressiveness traits in colon cancer cells. In order to study whether ECE1c exerts a malignant effect in GBM, we designed an ECE1c mutant by switching a putative ubiquitination lysine proximal to the phospho-serines Lys-6-to-Arg (i.e., K6R). This ECE1c(K6R) mutant was stably expressed in U87MG, T98G, and U251 GBM cells, and their behavior was compared to either mock or wild-type ECE1c-expressing clone cells. ECE1c(K6R) behaved as a highly stable protein in all cell lines, and its expression promoted self-renewal and the enrichment of a stem-like population characterized by enhanced neurospheroid formation, as well as increased expression of stem-like surface markers. These ECE1c(K6R)-derived GSC-like cells also displayed enhanced resistance to the GBM-related chemotherapy drugs temozolomide and gemcitabine and increased expression of the ABCG2 efflux pump. In addition, ECE1c(K6R) cells displayed enhanced metastasis-associated traits, such as the modulation of adhesion and the enhancement of cell migration and invasion. In conclusion, the acquisition of a GSC-like phenotype, together with heightened chemoresistance and invasiveness traits, allows us to suggest phospho-ECE1c as a novel marker for poor prognosis as well as a potential therapeutic target for GBM. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.3390/cells12030506 | |
dc.identifier.eissn | 2073-4409 | |
dc.identifier.uri | https://doi.org/10.3390/cells12030506 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/92437 | |
dc.identifier.wosid | WOS:000929317400001 | |
dc.issue.numero | 3 | |
dc.language.iso | en | |
dc.revista | Cells | |
dc.rights | acceso restringido | |
dc.subject | glioblastoma | |
dc.subject | stemness | |
dc.subject | endothelin | |
dc.subject | CK2 | |
dc.subject | aggressiveness | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Cancer Stem Cell and Aggressiveness Traits Are Promoted by Stable Endothelin-Converting Enzyme-1c in Glioblastoma Cells | |
dc.type | artículo | |
dc.volumen | 12 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |